These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32231271)

  • 21. Unexpected Functional Divergence of Bat Influenza Virus NS1 Proteins.
    Turkington HL; Juozapaitis M; Tsolakos N; Corrales-Aguilar E; Schwemmle M; Hale BG
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway.
    Vrijens P; Noppen S; Boogaerts T; Vanstreels E; Ronca R; Chiodelli P; Laporte M; Vanderlinden E; Liekens S; Stevaert A; Naesens L
    J Gen Virol; 2019 Apr; 100(4):583-601. PubMed ID: 30762518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.
    Meng L; Su Y; Yang F; Xiao S; Yin Z; Liu J; Zhong J; Zhou D; Yu F
    Bioorg Med Chem; 2019 Dec; 27(23):115147. PubMed ID: 31635892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palmitoylation Contributes to Membrane Curvature in Influenza A Virus Assembly and Hemagglutinin-Mediated Membrane Fusion.
    Chlanda P; Mekhedov E; Waters H; Sodt A; Schwartz C; Nair V; Blank PS; Zimmerberg J
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic Modification Is Regulated by the Interaction of Influenza A Virus Nonstructural Protein 1 with the
    Liu S; Liu L; Xu G; Cao Z; Wang Q; Li S; Peng N; Yin J; Yu H; Li M; Xia Z; Zhou L; Lin Y; Wang X; Li Q; Zhu C; Yang X; Wang J; She Y; Lu M; Zhu Y
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation.
    Liu G; Lu Y; Liu Q; Zhou Y
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H9N2 Influenza Virus Infections in Human Cells Require a Balance between Neuraminidase Sialidase Activity and Hemagglutinin Receptor Affinity.
    Arai Y; Elgendy EM; Daidoji T; Ibrahim MS; Ono T; Sriwilaijaroen N; Suzuki Y; Nakaya T; Matsumoto K; Watanabe Y
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycosylation of the Hemagglutinin Protein of H5N1 Influenza Virus Increases Its Virulence in Mice by Exacerbating the Host Immune Response.
    Zhao D; Liang L; Wang S; Nakao T; Li Y; Liu L; Guan Y; Fukuyama S; Bu Z; Kawaoka Y; Chen H
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the infectivity and inflammatory response of influenza virus by Arbidol hydrochloride in vitro and in vivo (mice and ferret).
    Wang Y; Ding Y; Yang C; Li R; Du Q; Hao Y; Li Z; Jiang H; Zhao J; Chen Q; Yang Z; He Z
    Biomed Pharmacother; 2017 Jul; 91():393-401. PubMed ID: 28475918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of inhibitors of influenza virus membrane fusion: synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series.
    Brancato V; Peduto A; Wharton S; Martin S; More V; Di Mola A; Massa A; Perfetto B; Donnarumma G; Schiraldi C; Tufano MA; de Rosa M; Filosa R; Hay A
    Antiviral Res; 2013 Aug; 99(2):125-35. PubMed ID: 23707194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
    Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic Effects of Substitutions within the Receptor Binding Site of Highly Pathogenic Avian Influenza H5N1 Virus Observed during Human Infection.
    Eggink D; Spronken M; van der Woude R; Buzink J; Broszeit F; McBride R; Pawestri HA; Setiawaty V; Paulson JC; Boons GJ; Fouchier RAM; Russell CA; de Jong MD; de Vries RP
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Single Mutation at Position 190 in Hemagglutinin Enhances Binding Affinity for Human Type Sialic Acid Receptor and Replication of H9N2 Avian Influenza Virus in Mice.
    Teng Q; Xu D; Shen W; Liu Q; Rong G; Li X; Yan L; Yang J; Chen H; Yu H; Ma W; Li Z
    J Virol; 2016 Nov; 90(21):9806-9825. PubMed ID: 27558420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.
    Shen C; Chen J; Li R; Zhang M; Wang G; Stegalkina S; Zhang L; Chen J; Cao J; Bi X; Anderson SF; Alefantis T; Zhang M; Cai X; Yang K; Zheng Q; Fang M; Yu H; Luo W; Zheng Z; Yuan Q; Zhang J; Wai-Kuo Shih J; Kleanthous H; Chen H; Chen Y; Xia N
    Sci Transl Med; 2017 Oct; 9(412):. PubMed ID: 29046433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enabling the 'host jump': structural determinants of receptor-binding specificity in influenza A viruses.
    Shi Y; Wu Y; Zhang W; Qi J; Gao GF
    Nat Rev Microbiol; 2014 Dec; 12(12):822-31. PubMed ID: 25383601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Competitive Cooperation of Hemagglutinin and Neuraminidase during Influenza A Virus Entry.
    Du R; Cui Q; Rong L
    Viruses; 2019 May; 11(5):. PubMed ID: 31137516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Small Molecule Targeting the Hemagglutinin Stalk of Influenza Viruses.
    Kim JI; Lee S; Lee GY; Park S; Bae JY; Heo J; Kim HY; Woo SH; Lee HU; Ahn CA; Bang HJ; Ju HS; Ok K; Byun Y; Cho DJ; Shin JS; Kim DY; Park MS; Park MS
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31167918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza A surface glycosylation and vaccine design.
    Wu CY; Lin CW; Tsai TI; Lee CD; Chuang HY; Chen JB; Tsai MH; Chen BR; Lo PW; Liu CP; Shivatare VS; Wong CH
    Proc Natl Acad Sci U S A; 2017 Jan; 114(2):280-285. PubMed ID: 28028222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza virus matrix protein M1 interacts with SLD5 to block host cell cycle.
    Zhu L; Zhao W; Lu J; Li S; Zhou K; Jiang W; Duan X; Fu L; Yu B; Cai KQ; Gao GF; Liu W; Fang M
    Cell Microbiol; 2019 Aug; 21(8):e13038. PubMed ID: 31050118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza A virus utilizes a suboptimal Kozak sequence to fine-tune virus replication and host response.
    Wang J; Peng Y; Zhao L; Cao M; Hung T; Deng T
    J Gen Virol; 2015 Apr; 96(Pt 4):756-766. PubMed ID: 25519170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.